Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Abstract Cancer is a major health burden worldwide, and despite continuous advances in medical therapies, resistance to standard drugs and adverse effects still represent an important cause of therapeutic failure. There is a growing evidence that gut bacteria can affect the response to chemo- and im...
Main Authors: | Concetta Panebianco, Angelo Andriulli, Valerio Pazienza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Microbiome |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40168-018-0483-7 |
Similar Items
-
Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes
by: Saad Rama, et al.
Published: (2012-11-01) -
Microbiota Manipulation by Probiotics Administration as Emerging Tool in Cancer Prevention and Therapy
by: Concetta Panebianco, et al.
Published: (2020-05-01) -
Drug–Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics
by: Ali Mohamed, et al.
Published: (2021-03-01) -
Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy
by: Peng Cheng, et al.
Published: (2021-09-01) -
The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
by: Romy Aarnoutse, et al.
Published: (2019-08-01)